Assessing Barriers to Opioid Use Disorder Treatment Act
Official title: A bill to require the Comptroller General of the United States to study and report on State Medicaid agencies' options related to the distribution of substance… Show full official titleShow less
Official title: A bill to require the Comptroller General of the United States to study and report on State Medicaid agencies' options related to the distribution of substance use disorder treatment medications under the Medicaid program.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
Assessing Barriers to Opioid Use Disorder Treatment Act
This bill requires the Government Accountability Office to report on barriers to the provision of medication used to treat substance use disorders (e.g., buprenorphine) under Medicaid distribution models (e.g., provider purchasing, storage, and administration of medications).
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2909: Assessing Barriers to Opioid Use Disorder Treatment Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-2909/
"S. 2909: Assessing Barriers to Opioid Use Disorder Treatment Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2909/.
S. 2909, 115th Cong. (2026), https://openamerica.io/bill/115-S-2909/.
[S. 2909: Assessing Barriers to Opioid Use Disorder Treatment Act](https://openamerica.io/bill/115-S-2909/)